13F-HR filed by Medicxi Ventures Management (Jersey) Ltd
Medicxi Ventures Management (Jersey) Ltd filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-10-27, with 5 holding rows worth $209,408,000.
- Accession
- 0000950123-20-010496
- Filer
- CIK 1715579
- Filed
- 2020-10-27
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2020
A holdings report, 5 entries on the cover page, a total value of $209,408,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $209,408,000 with VALUE read as thousands by filing date, 13F file number 028-19833. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFrancesco De Rubertis
- included managerKevin Stuart Johnson
- included managerMichele Ollier
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VAXCYTE INC COM | 92243G108 | Stock | 1,887,478 | $93,203,000 | thousands by filing date | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 2,067,861 | $75,828,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 1,600,000 | $19,200,000 | thousands by filing date | |
| CHECKMATE PHARMACEUTICALS IN | 162818108 | COM | 1,501,716 | $17,284,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 1,570,000 | $3,893,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-20-010496 | this filing | 2020-10-27 | acceptance time not in the bulk data set |